Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2009
10/15/2009US20090258091 Compositions and methods for treating neurodegenerative diseases
10/15/2009US20090258084 Mono and Combination Therapy with a M1/M4 Muscarinic Agonist (Sabcomeline) for Treatment of Cognitive Disorders in Schizophrenia
10/15/2009US20090258026 Anti-notch1 nrr antibodies and methods using same
10/15/2009US20090258009 Protofibril selective antibodies and the use thereof
10/15/2009US20090257990 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
10/15/2009US20090257987 Method of generating dopamine-secreting cells
10/15/2009US20090257975 Solid and Semi-Solid Polymeric Ionic Conjugates
10/15/2009DE102008017853A1 Thienopyrimidine Thienopyrimidines
10/15/2009DE102008017496A1 New boswellic acid derivatives are microsomal prostaglandin E-1 synthesis inhibitors, useful to treat e.g. rheumatoid arthritis, inflammatory bowel disease, asthma, feverish and painful conditions, cancers, emphysema and multiple sclerosis
10/15/2009CA2725425A1 Homocysteine synthase inhibitor
10/15/2009CA2721119A1 Anhydrous crystal form of orvepitant maleate
10/15/2009CA2720879A1 Substituted sulfonamide derivatives
10/15/2009CA2720760A1 Oligomer-aryloxy-substituted propanamine conjugates
10/15/2009CA2720613A1 2-sulfonylamino-4-heteroaryl butyramide antagonists of ccr10
10/15/2009CA2711212A1 Treatment of migraines without aura in pregnant women by inhalation of dioxygen gas
10/15/2009CA2710398A1 Methods and compositions for targeting polyubiquitin
10/14/2009EP2108655A1 Immune-modulating peptide
10/14/2009EP2108651A1 Crystalline form I of 2-methyl-4-(4-methyl-1-piperazinyl) 10H thieno[2,3-B][1,5] benzodiazepine
10/14/2009EP2108649A1 Novel indol carboxylic acid bispyridyl carboxamide derivatives as 5-HT2c receptor antagonists
10/14/2009EP2108648A1 Selected CGRP antagonists, method for their manufacture and use as medicines
10/14/2009EP2108644A1 N-(methyl)-pyridin-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins
10/14/2009EP2108376A2 Prevention and treatment of amyloidogenic disease
10/14/2009EP2108370A1 Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
10/14/2009EP2108018A2 8-oxa-1,4-diazaspiro [4,5] dec-3-en-1-yl and 1,4,8-triazaspiro [4,5] dec-3-en-1-yl acetamides as glyti transporter inhibitors in treatment of neurological and neuropsychiatric disorders
10/14/2009EP1877367B1 Acetylene derivatives
10/14/2009EP1848446B1 Use of iron(iii) complex compounds
10/14/2009EP1791537B1 3-arylthioindole-2-carboxamide derivatives and analogs thereof as inhibitors of casein kinase i
10/14/2009EP1755604B1 Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin
10/14/2009EP1740183B1 Novel use for pde5 inhibitors
10/14/2009EP1729771B1 Pyridyl derivatives and their use as mglu5 receptor antagonists
10/14/2009EP1599476B1 Novel diazabicyclic aryl derivatives
10/14/2009EP1554572B1 Compositions and methods for modulating blood-brain barrier transport
10/14/2009EP1474158B1 Prevention and treatment of oxidative stress disorders by compounds which elevate intracellular levels of glutathione or phase ii detoxification enzymes
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009EP1356046B1 Cytokine receptor zcytor19
10/14/2009EP1337527B1 Indolylmaleimide derivatives as protein kinase c inhibitors
10/14/2009EP1303302B1 Use of strains of the parapox ovis virus against organ fibrosis
10/14/2009EP1153129B1 Method of treating restenosis by antisense targeting of c-myc
10/14/2009CN101558080A Modulation of angiogenesis by a-beta peptide fragments
10/14/2009CN101558073A Method for the production of high-purity 4a, 5, 9, 10, 11, 12,-hexahydro-6h-benzofuro [3a, 3, 2-ef] [2] benzazepine, and the derivatives thereof
10/14/2009CN101558065A Oxazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
10/14/2009CN101558057A 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders
10/14/2009CN101558038A Novel curcumin derivative
10/14/2009CN101557820A Omega conotoxins
10/14/2009CN101557810A Novel 2 -imidazoles as ligands for trace amine associated receptors (taar)
10/14/2009CN101555477A Heavy and light chain variable region gene of monoclonal antibody resisting human amyloid
10/14/2009CN101555476A Small interfering RNA, screening method and application in preparing medicament for treating neuropathic pains
10/14/2009CN101555227A Preparation method of high purity bulleyaconitine A
10/14/2009CN101555210A Method for preparing pregabalin
10/14/2009CN101554440A Pharmaceutical composition and preparation method thereof
10/14/2009CN101554436A Traditional Chinese medicine for treating diabetic stubborn insomnia
10/14/2009CN101554423A Dealcoholic sobering-up pharmaceutical preparation and preparing method thereof
10/14/2009CN101554418A Traditional Chinese medicine for treating diabetic peripheral neuritis
10/14/2009CN101554405A Selfheal, mulberry leaf and wild chrysanthemum dripping pills and preparation method thereof
10/14/2009CN101554397A Applications of eucommia ulmoide total alkaloid
10/14/2009CN101554391A American ginseng acanthopanax traditional Chinese medicine preparation for treating neurasthenia
10/14/2009CN101554370A Syringin for injection, preparation method and application thereof
10/14/2009CN101554368A Tetrodotoxin composition formulation stable at room temperature and used for injection
10/14/2009CN101554235A Sober-up oral liquid made from fruit vinegar with persimmon pulp
10/14/2009CN101554210A A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
10/14/2009CN100549014C Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
10/14/2009CN100549008C Substituted oxazolidinones and their use in the field of blood coagulation
10/14/2009CN100548980C Isoindoline derivative
10/14/2009CN100548348C Internal-applied traditional Chinese medicine composition for treating neurasthenia
10/14/2009CN100548336C Orally-administered traditional Chinese medicine composition for treating intercostal neuralgia
10/14/2009CN100548333C Health-care tea for improving sleep function
10/14/2009CN100548332C Compound extractive of general glycoside of Cape jasmine, preparation and application
10/14/2009CN100548331C Compound cape-jasmine salted-fermented beans total extract and its preparation and use
10/14/2009CN100548325C Medicinal composition with corydalis and Radix Angelicae pubescentis, its production and use
10/14/2009CN100548303C Combination product comprising melagatran and dexamethasone
10/14/2009CN100548302C Female hormone-containing patch
10/14/2009CN100548299C Excitatory amino acid receptor antagonists
10/14/2009CN100548290C Use of sulfamate derivative for treating impulse control disorders
10/14/2009CN100548288C Memory fixation accelerator
10/14/2009CN100548278C New preparation method for raising rate of packaging microspheres of naltrexone
10/14/2009CA2629057A1 Control of diseases associated with decrease of t-regulatory cells with a preparation of extended freeze-dried killed bacteria
10/13/2009US7601850 less hypercalcemic than 1a,25 dihydroxy vitamin D3; bone disorders, psoriasis
10/13/2009US7601837 Quinoline derivatives and their use as 5-HT6 ligands
10/13/2009US7601836 Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7
10/13/2009US7601817 For treating a disease medicated by TNF alpha including acute and chronic immune and immunoregulatory disorders and rheumatoid or osteo-arthritis
10/13/2009US7601816 Transcripts harboring inton 1, or fragment thereof; preventing or treating Alzheimer's Disease; ameliorating a neurodegenerative condition; modulating amyloid precursor protein; selectively inhibiting COX-3 or PCOX-1a activity
10/13/2009US7601812 Schistosoma protein for use in treatment of organ-specific autoimmune diseases
10/13/2009US7601809 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs
10/13/2009US7601740 urea substituted piperidine derivatives; may confer antipsychotic and anti-dyskinetic efficacy in humans; use as novel therapeutics, sometimes in conjunction with other therapeutics, for Parkinson's Disease, related human neurodegenerative diseases, and psychosis
10/13/2009US7601734 Cyclic amine compound
10/13/2009US7601730 Carboxylic acid derivatives, their preparation and use
10/13/2009US7601727 Such as 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile; janus kinase 3 inhibitors; immunosuppressive agents; asthma
10/13/2009US7601718 1,5-Dihydro-pyrazolo[4,3-c]pyridazin-6-one derivatives; glycogen synthase kinase-3 (CSK) inhibitors; nervous system, psychological, and neurodegenerative disorders; diabetes, psychiatry, multiple sclerosis (MS), myocardial infarction, reperfusion/ischemia, alopecia, and stroke
10/13/2009US7601712 Such as (1)-2-(4-chloro-3-((2-chloro-4-(((2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-ly)methoxy)benzoyl)amino)phenyl)-2-methylpropanoic acid; prostaglandin receptor agonists
10/13/2009US7601534 Maintaining a non-differentiated state of human stem cells, while allowing cell division of said human stem cells
10/13/2009US7601518 Secretion of neublastin
10/13/2009US7601354 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
10/13/2009US7601352 Monoclonal antibodies and antigen binding fragments thereof capable of binding TrkA and inhibiting the functional activation of TrkA
10/13/2009US7601344 Von Hippel-Lindau (VHL) gene in cancer cells which express neuropeptide Y, neurofilament, and microtubule associated protein 2; plasmids; Parkinson's disease, amyotrophic lateral sclerosis, Huntington's chorea, Alzheimer's disease, brain infarction, spinal cord injury, brain contusion or malignant tumor
10/13/2009US7601337 Delivery of antipsychotics through an inhalation route
10/13/2009CA2455246C Drug preparation comprising .alpha.-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ace) and its use for the treatment of neurodegenerative diseases
10/13/2009CA2447807C Abuse resistant pharmaceutical composition containing capsaicin
10/13/2009CA2445276C Aripiprazole oral solution
10/13/2009CA2414665C Rapidly disintegrating dosage form for releasing active ingredients in the oral cavity or in body cavities
10/13/2009CA2386974C Benzodiazepine derivatives for use in acute or chronic neurological disorders
1 ... 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 ... 1833